XML 56 R45.htm IDEA: XBRL DOCUMENT
v3.5.0.2

INVESTMENTS (Details) - USD ($) |  |  |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | ---
Jul. 26, 2016 | Jan. 28, 2016 | May 01, 2015 | Sep. 30, 2016 | Sep. 30, 2015 | Jun. 30, 2016
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Income (loss) from equity method investments |  |  |  | $ 9,579,000 | $ 4,590,000 |
Innovatix, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Equity method investment, ownership percentage |  |  |  |  |  | 50.00%
Premier Supply Chain Improvement, Inc | FFF Enterprises, Inc. |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Subsidiary of limited liability company or limited partnership, ownership interest, as a percent | 49.00% |  |  |  |  |
Cash portion of acquisition price | $ 65,700,000 |  |  |  |  |
Initial investment | 75,900,000 |  |  |  |  |
Total acquisition price | 7,400,000 |  |  |  |  |
Deferred taxes attributed to fair value of put and call rights | $ 2,800,000 |  |  |  |  |
Income (loss) from equity method investments |  |  |  | $ 3,000,000 |  |
Equity method investment, ownership percentage |  |  |  | 49.00% |  |
Premier Supply Chain Improvement, Inc | BloodSolutions, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Net income from unconsolidated affiliates |  |  |  | $ 0 |  |
Premier Supply Chain Improvement, Inc | PharmaPoint, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Income (loss) from equity method investments |  |  |  | (100,000) | (100,000) |
Premier Supply Chain Improvement, Inc | Innovatix, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Income (loss) from equity method investments |  |  |  | $ 6,500,000 | $ 4,400,000 |
Equity method investment, ownership percentage |  |  |  | 50.00% |  |
Premier Supply Chain Improvement, Inc | Long-term investments | FFF Enterprises, Inc. |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Carrying value of equity method investment |  |  |  | $ 78,900,000 |  |
Premier Supply Chain Improvement, Inc | Long-term investments | BloodSolutions, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Carrying value of equity method investment |  |  |  | 2,200,000 |  | $ 2,200,000
Premier Supply Chain Improvement, Inc | Long-term investments | PharmaPoint, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Carrying value of equity method investment |  |  |  | 4,500,000 |  | 4,600,000
Premier Supply Chain Improvement, Inc | Long-term investments | Innovatix, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Carrying value of equity method investment |  |  |  | $ 9,100,000 |  | $ 9,000,000
Common Class B Unit | Premier Supply Chain Improvement, Inc | BloodSolutions, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Subsidiary of limited liability company or limited partnership, ownership interest, as a percent |  | 15.00% |  |  |  |
Common limited partners, units acquired, units (in shares) |  | 5,250,000 |  |  |  |
Common limited partners, units acquired, value |  | $ 2,300,000 |  |  |  |
Common Class B Unit | Premier Supply Chain Improvement, Inc | PharmaPoint, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Subsidiary of limited liability company or limited partnership, ownership interest, as a percent |  |  |  | 28.00% |  | 28.00%
Common limited partners, units acquired, units (in shares) |  |  |  | 5,000,000 |  | 5,000,000
Common Class B Unit | Premier Supply Chain Improvement, Inc | Nations Pharmaceuticals, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Subsidiary of limited liability company or limited partnership, ownership interest, as a percent |  |  | 72.00% |  |  |
Common Class A Unit | Premier Supply Chain Improvement, Inc | Nations Pharmaceuticals, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Common limited partners, units acquired, units (in shares) |  |  | 13,000,000 |  |  |

X
- Definition Common Limited Partners Units Acquired + References No definition available. + Details
Name: | pinc_CommonLimitedPartnersUnitsAcquired
Namespace Prefix: | pinc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Common Limited Partners Units Acquired, Value + References No definition available. + Details
Name: | pinc_CommonLimitedPartnersUnitsAcquiredValue
Namespace Prefix: | pinc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=66022249&loc=d3e33749-111570 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(12)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(10)) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=66022249&loc=d3e33749-111570 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(13)(f)) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 + Details
Name: | us-gaap_IncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -Section S99 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=50485924&loc=d3e611443-123010 + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pinc_InnovatixLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=pinc_PremierSupplyChainImprovementIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pinc_FFFEnterprisesInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pinc_BloodSolutionsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pinc_PharmaPointLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=pinc_NoncurrentInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=pinc_CommonClassBUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pinc_NationsPharmaceuticalsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=pinc_CommonClassAUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |